120 related articles for article (PubMed ID: 11549453)
1. Derivatives of (2R,3R,4S)-2-aminomethylpyrrolidine-3,4-diol are selective alpha-mannosidase inhibitors.
Popowycz F; Gerber-Lemaire S; Demange R; Rodriguez-García E; Asenjo AT; Robina I; Vogel P
Bioorg Med Chem Lett; 2001 Sep; 11(18):2489-93. PubMed ID: 11549453
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and glycosidase inhibitory activities of 2-(aminoalkyl)pyrrolidine-3,4-diol derivatives.
Carmona AT; Popowycz F; Gerber-Lemaire S; Rodríguez-García E; Schütz C; Vogel P; Robina I
Bioorg Med Chem; 2003 Nov; 11(23):4897-911. PubMed ID: 14604651
[TBL] [Abstract][Full Text] [Related]
3. New leads for selective inhibitors of alpha-L-fucosidases. Synthesis and glycosidase inhibitory activities of [(2R,3S,4R)-3,4-dihydroxypyrrolidin-2-yl]furan derivatives.
Robina I; Moreno-Vargas AJ; Fernández-Bolaños JG; Fuentes J; Demange R; Vogel P
Bioorg Med Chem Lett; 2001 Sep; 11(18):2555-9. PubMed ID: 11549468
[TBL] [Abstract][Full Text] [Related]
4. Functionalized pyrrolidines inhibit alpha-mannosidase activity and growth of human glioblastoma and melanoma cells.
Fiaux H; Popowycz F; Favre S; Schütz C; Vogel P; Gerber-Lemaire S; Juillerat-Jeanneret L
J Med Chem; 2005 Jun; 48(13):4237-46. PubMed ID: 15974577
[TBL] [Abstract][Full Text] [Related]
5. Novel 2-[(benzylamino)methyl]pyrrolidine-3,4-diol derivatives as alpha-mannosidase inhibitors and with antitumor activities against hematological and solid malignancies.
Bello C; Cea M; Dal Bello G; Garuti A; Rocco I; Cirmena G; Moran E; Nahimana A; Duchosal MA; Fruscione F; Pronzato P; Grossi F; Patrone F; Ballestrero A; Dupuis M; Sordat B; Nencioni A; Vogel P
Bioorg Med Chem; 2010 May; 18(9):3320-34. PubMed ID: 20346684
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of a potent aminocyclitol alpha-mannosidase inhibitor, 1L-(1,2,3,5/4)-5-amino-4-O-methyl-1,2,3,4-cyclopentanetetrol.
Ogawa S; Morikawa T
Bioorg Med Chem Lett; 2000 May; 10(10):1047-50. PubMed ID: 10843213
[TBL] [Abstract][Full Text] [Related]
7. α-D-mannose derivatives as models designed for selective inhibition of Golgi α-mannosidase II.
Poláková M; Šesták S; Lattová E; Petruš L; Mucha J; Tvaroška I; Kóňa J
Eur J Med Chem; 2011 Mar; 46(3):944-52. PubMed ID: 21295890
[TBL] [Abstract][Full Text] [Related]
8. Virtual screening and QSAR study of some pyrrolidine derivatives as α-mannosidase inhibitors for binding feature analysis.
Moorthy NS; Brás NF; Ramos MJ; Fernandes PA
Bioorg Med Chem; 2012 Dec; 20(24):6945-59. PubMed ID: 23151473
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of alpha-mannosidase inhibitory activity of three deoxy derivatives of mannostatin A.
Ogawa S; Morikawa T
Bioorg Med Chem Lett; 1999 Jun; 9(11):1499-504. PubMed ID: 10386924
[TBL] [Abstract][Full Text] [Related]
10. Novel tools for the study of class I alpha-mannosidases: a chromogenic substrate and a substrate-analog inhibitor.
Desmet T; Nerinckx W; Stals I; Callewaert N; Contreras R; Claeyssens M
Anal Biochem; 2002 Aug; 307(2):361-7. PubMed ID: 12202255
[TBL] [Abstract][Full Text] [Related]
11. Cyclic amidine sugars as transition-state analogue inhibitors of glycosidases: potent competitive inhibitors of mannosidases.
Heck MP; Vincent SP; Murray BW; Bellamy F; Wong CH; Mioskowski C
J Am Chem Soc; 2004 Feb; 126(7):1971-9. PubMed ID: 14971930
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of modified D-mannose core derivatives and their impact on GH38 α-mannosidases.
Poláková M; Horák R; Šesták S; Holková I
Carbohydr Res; 2016 Jun; 428():62-71. PubMed ID: 27152630
[TBL] [Abstract][Full Text] [Related]
13. Marked differences in the swainsonine inhibition of rat liver lysosomal alpha-D-mannosidase, rat liver Golgi mannosidase II, and jack bean alpha-D-mannosidase.
Tulsiani DR; Broquist HP; Touster O
Arch Biochem Biophys; 1985 Jan; 236(1):427-34. PubMed ID: 3917650
[TBL] [Abstract][Full Text] [Related]
14. A practical synthesis of kifunensine analogues as inhibitors of endoplasmic reticulum alpha-mannosidase I.
Hering KW; Karaveg K; Moremen KW; Pearson WH
J Org Chem; 2005 Nov; 70(24):9892-904. PubMed ID: 16292820
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of potent glycosidase inhibitors: N-phenyl cyclic isourea derivatives of 5-amino- and 5-amino-C-(hydroxymethyl)-1,2,3,4-cyclopentanetetraols.
Uchida C; Kimura H; Ogawa S
Bioorg Med Chem; 1997 May; 5(5):921-39. PubMed ID: 9208102
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of 5-amino-5-deoxy-D-mannopyranose and 1,5-dideoxy-1,5-imino-D-mannitol, and inhibition of alpha- and beta-D-mannosidases.
Legler G; Jülich E
Carbohydr Res; 1984 May; 128(1):61-72. PubMed ID: 6234061
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of mannostatins A and B from myo-inositol.
Ogawa S; Yu Y
Bioorg Med Chem; 1995 Jul; 3(7):939-43. PubMed ID: 7582971
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of isofagomine and its derivatives as potent glycosidase inhibitors.
Dong W; Jespersen T; Bols M; Skrydstrup T; Sierks MR
Biochemistry; 1996 Feb; 35(8):2788-95. PubMed ID: 8611585
[TBL] [Abstract][Full Text] [Related]
19. Studies on the glycosidases in jack bean meal. I. Isolation and properties of alpha-mannosidase.
Li YT
J Biol Chem; 1967 Dec; 242(23):5474-80. PubMed ID: 12325362
[No Abstract] [Full Text] [Related]
20. Synthesis and enzymatic evaluation of five-membered iminocyclitols and a pseudodisaccharide.
Saotome C; Kanie Y; Kanie O; Wong CH
Bioorg Med Chem; 2000 Sep; 8(9):2249-61. PubMed ID: 11026538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
